mktcap_usd=225325
ConsensRecom=2.46
earning_yield=11.83%
growth=10.70%
dilution=-1.20%
div_ratio=33.77%
sh_payout_ratio=43.29%
margin=28.76%
cfmargin=23.37%
ratiopaid=1.74
sratiopaid=21.00%
ratioConsens=1.29
Description
Pfizer Inc. is a research-based biopharmaceutical company. The Company is engaged in the discovery, development, manufacture, marketing, sale and distribution of biopharmaceutical products around the world. The Company operations through two segments: Biopharma and PC1. Biopharma is a science-based medicines business that includes six therapeutic areas, such as Vaccines, Hospital, Oncology, Internal Medicine, Rare Disease, and Inflammation & Immunology. PC1 is its global contract development and manufacturing organization and supplier of specialty active pharmaceutical ingredients. Its Vaccines include Comirnaty/BNT162b2, the Prevnar family, Nimenrix and others. Its Oncology products include Ibrance, Xtandi, Inlyta, Sutent, Retacrit, Lorbrena and Braftovi. Its Internal Medicine products include Eliquis and the Premarin family. Its Inflammation & Immunology products include Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis and Cibinqo. It also offers Rimegepant and Zavegepant.
Income and Cashflow Statements USD
| EndDate | 2016-12-31 | 2017-12-31 | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | mean | std |
|---|---|---|---|---|---|---|---|---|---|
| sourceDate | 2017-02-23 | 2018-02-22 | 2021-02-25 | 2021-02-25 | 2022-02-24 | 2022-02-24 | 2023-02-23 | NaN | NaN |
| period | 12M | 12M | 12M | 12M | 12M | 12M | 12M | NaN | NaN |
| rev | 52824 | 52546 | 40825 | 41172 | 41651 | 81288 | 100330 | 58662 | 23213 |
| revgrowth | NaN | -0.53% | -25.24% | 0.85% | 1.16% | 66.87% | 21.05% | 10.69% | 31.20% |
| earn | 7214 | 21309 | 11152 | 16273 | 9159 | 21980 | 31372 | 16923 | 8582 |
| earnx | 7197 | 11907 | 3228 | 10516 | 6630 | 22414 | 31366 | 13323 | 10019 |
| margin | 13.66% | 40.55% | 27.32% | 39.52% | 21.99% | 27.04% | 31.27% | 28.76% | 9.49% |
| xmargin | 13.62% | 22.66% | 7.91% | 25.54% | 15.92% | 27.57% | 31.26% | 20.64% | 8.39% |
| earningyld | 3.71% | 9.80% | 4.36% | 7.47% | 4.51% | 6.65% | 11.70% | 6.89% | 3.01% |
| cfop | 16193 | 16802 | 15827 | 12587 | 14403 | 32580 | 29267 | 19666 | 7872 |
| cfinv | -7791 | -4740 | 4525 | -3945 | -4271 | -22546 | -15783 | -7793 | 8848 |
| cffin | -9228 | -13350 | -20441 | -8485 | -9649 | -9816 | -14834 | -12258 | 4301 |
| cfopmargin | 30.65% | 31.98% | 38.77% | 30.57% | 34.58% | 40.08% | 29.17% | 33.69% | 4.28% |
| cfinvmargin | -14.75% | -9.02% | 11.08% | -9.58% | -10.25% | -27.74% | -15.73% | -10.86% | 11.62% |
| cffinmargin | -17.47% | -25.41% | -50.07% | -20.61% | -23.17% | -12.08% | -14.79% | -23.37% | 12.65% |
| shares | 6037 | 5938 | 5858 | 5562 | 5520 | 5595 | 5619 | 5733 | 207 |
| fx | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 0 |
| price | 32.2 | 36.6 | 43.6 | 39.2 | 36.8 | 59.0 | 47.7 | 42.2 | 9.00 |
| dilution | NaN | -1.65% | -1.35% | -5.18% | -0.76% | 1.34% | 0.44% | -1.19% | 2.26% |
| dividend | 7317 | 7659 | 7978 | 8043 | 8440 | 8729 | 8983 | 8164 | 590 |
| sharebb | NaN | 3407 | 3187 | 12259 | 1601 | -3570 | -1308 | 2596 | 5452 |
| ltdebtbb | NaN | -2140 | 629 | -3046 | -1178 | 938 | 3311 | -248 | 2329 |
| mgtbb | NaN | -4424 | -8647 | 8771 | -786 | -3719 | -3848 | -2109 | 5897 |
| divyld | 3.76% | 3.52% | 3.12% | 3.69% | 4.15% | 2.64% | 3.35% | 3.46% | 0.49% |
| sharebbyld | NaN | 1.65% | 1.35% | 5.18% | 0.76% | -1.34% | -0.44% | 1.19% | 2.26% |
| mgtyld | NaN | -2.03% | -3.38% | 4.02% | -0.39% | -1.13% | -1.44% | -0.72% | 2.53% |
Balance Sheet
| EndDate | 2016-12-31 | 2017-12-31 | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | mean | std |
|---|---|---|---|---|---|---|---|---|---|
| sourceDate | 2017-02-23 | 2018-02-22 | 2021-02-25 | 2021-02-25 | 2022-02-24 | 2022-02-24 | 2023-02-23 | NaN | NaN |
| mktcap | 194364 | 217495 | 255712 | 217928 | 203194 | 330359 | 268030 | 241012 | 47647 |
| mktcapgrowth | NaN | 11.24% | 16.19% | -15.99% | -7.00% | 48.60% | -20.91% | 5.36% | 25.77% |
| totAsset | 171615 | 171797 | 159422 | 167594 | 154229 | 181476 | 197205 | 171905 | 14252 |
| assetgrowth | NaN | 0.11% | -7.48% | 5.00% | -8.31% | 16.27% | 8.31% | 2.32% | 9.50% |
| curAsset | 38949 | 41141 | 49926 | 32803 | 35067 | 59693 | 51259 | 44120 | 9771 |
| curAssetPct | 22.70% | 23.95% | 31.32% | 19.57% | 22.74% | 32.89% | 25.99% | 25.59% | 4.86% |
| totLiab | 112071 | 100489 | 96015 | 104450 | 90991 | 104276 | 101545 | 101405 | 6704 |
| totLiabPct | 65.30% | 58.49% | 60.23% | 62.32% | 59.00% | 57.46% | 51.49% | 59.19% | 4.30% |
| curLiab | 31115 | 30427 | 31858 | 37304 | 25920 | 42671 | 42138 | 34490 | 6346 |
| curLiabPct | 18.13% | 17.71% | 19.98% | 22.26% | 16.81% | 23.51% | 21.37% | 19.97% | 2.52% |
| ltDebt | 31398 | 33538 | 32909 | 35955 | 37133 | 36195 | 32884 | 34287 | 2133 |
| ltDebtPct | 18.30% | 19.52% | 20.64% | 21.45% | 24.08% | 19.94% | 16.68% | 20.09% | 2.36% |
| Equity | 59544 | 71308 | 63407 | 63144 | 63238 | 77200 | 95660 | 70500 | 12621 |
| EquityPct | 34.70% | 41.51% | 39.77% | 37.68% | 41.00% | 42.54% | 48.51% | 40.81% | 4.30% |
| PB | 3.26 | 3.05 | 4.03 | 3.45 | 3.21 | 4.28 | 2.80 | 3.44 | 53.19% |
Beta
len=92.0
mean=1.93%
sd=21.86%
alpha=0.04%
beta=60.82%
r_sq=20.74%
lastdate=2023-03-17
firstdate=2016-05-31
logret1y=-25.54%
Financial Snapshot
CompanyName=Pfizer Inc.
ID=1
Name=Ordinary Shares
Ticker=PFE
ISIN=None
RIC=PFE
DisplayRIC=PFE.N
InstrumentPI=270514
QuotePI=1091044
InstrumentPermID=8590930286
QuotePermID=55838324860
Exchange=New York Stock Exchange
ExchangeCode=NYSE
ExchangeCountry=USA
CoStatus=Active
CoType=Equity Issue
LastModified=2023-03-09
LatestAvailableAnnual=2022-12-31
LatestAvailableInterim=2022-12-31
Employees=83000
SharesOut=5.644e+09
TotalFloat=5.611e+09
ReportingCurrency=USD
MostRecentExchange=1.0
Industry=Pharmaceuticals (NEC)
IndustryCode=5620104010
NPRICE=40.1
NHIG=56.3
NLOW=39.2
PDATE=2023-03-17
VOL10DAVG=26.8
EV=238422
MKTCAP=225325
AREV=100331
AEBITD=42693
ANIAC=31366
AEPSXCLXOR=5.47
AREVPS=17.5
ABVPS=17.0
ACSHPS=4.05
ACFSHR=6.36
ADIVSHR=1.60
AGROSMGN=65.5
AROEPCT=36.3
APR2REV=2.25
APEEXCLXOR=7.33
APRICE2BK=2.35
ConsRecom=2.46
TargetPrice=51.6
ProjLTGrowthRate=-13.3
ProjPE=11.5
ProjSales=69646
ProjSalesQ=16937
ProjEPS=3.48
ProjEPSQ=1.00
ProjProfit=19247
ProjDPS=1.68
quoteccy=USD
quotefx=100.00%
exchgccy=USD
exchgfx=100.00%
tick=None
exchg=None
Valuation
ticker=PFE
exchg=AMEX
RIC=PFE
CompanyName=Pfizer Inc.
ExchangeCode=NYSE
Industry=Pharmaceuticals (NEC)
IndustryCode=5620104010
sector=56 Healthcare
region=us
ccy=USD
fx=100.00%
mktcap_usd=225325
float_usd=223982
ConsensRecom=2.46
earning_yield=11.83%
growth=10.70%
dilution=-1.20%
margin=28.76%
searning_yield=8.21%
sgrowth=-17.80%
smargin=19.98%
sdilution=0.87%
projearning_yield=8.32%
earning_excl_yield=12.80%
div_ratio=33.77%
bb_ratio=9.52%
sh_payout_ratio=43.29%
PS=2.29
price=40.1
ratio=1.74
sratio=21.00%
sratiopaid=21.00%
ratioConsens=1.29
turnover=33.46%
cfmargin=23.37%
rdmargin=16.59%
scfmargin=11.65%
quoteccy=USD
quotefx=100.00%
ratiopaid=1.74
dt=2023-03-17
assetgrowth=2.32%
dlnfx=0